
GC35550
BRCA1-IN-2
Also known as [(2S)-2-[3-(1H-indol-3-yl)propanoylamino]-3-oxo-3-[[2-oxo-2-(4-phenylbutylamino)ethyl]amino]propyl] dihydrogen phosphate
BRCA1-IN-2 (compound 15) is a cell-permeable protein-protein interaction (PPI) inhibitor for BRCA1 with an IC50 of 0·31 μM and a Kd of 0·3 μM, which shows antitumor activities via the disruption of BRCA1 (BRCT)2/protein interactions
ChemicalCAS1622262-55-8MW544.54FormulaC26H33N4O7P
- CAS number
- 1622262-55-8
- Molecular weight
- 544.54
- Formula
- C26H33N4O7P
- Solubility
- Soluble in DMSO
- InChIKey
- TYEYIJQDNULZJQ-QHCPKHFHSA-N
- Catalogue number
- GC35550
- Brand
- GLPBIO
Computed properties PubChem CID 102369451 · XLogP 1.2 · TPSA 170 Ų · H-bond donors 6
- XLogP
- 1.2
- TPSA
- 170 Ų
- H-bond donors
- 6
- H-bond acceptors
- 7
- Rotatable bonds
- 15
- Heavy atoms
- 38
SMILES C1=CC=C(C=C1)CCCCNC(=O)CNC(=O)[C@H](COP(=O)(O)O)NC(=O)CCC2=CNC3=CC=CC=C32
Computed descriptors from PubChem (CID 102369451), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il